D006585Chemicals & DrugsD03.383.931.135240.999533Altretamineprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonObstetrics & Gynecology0.05998850.03336682research area of0.0412620.01572614subject area forMedicine-Hematology and Oncology3079898Richman CM, Podczaski E, Weiser PA, Herbst ALOncologyHexamethylmelamine, cyclophosphamide, adriamycin, cis-platinum chemotherapy as initial and second-line treatment of advanced ovarian carcinoma. Oncology. 1986; 43(1):12-7.Oncology1986-01-01T00:00:001986Hexamethylmelamine, cyclophosphamide, adriamycin, cis-platinum chemotherapy as initial and second-line treatment of advanced ovarian carcinoma.3019503Jacobs RH, Greenburg A, Bitran JD, Hoffman PC, Albain KS, Desser R, Potkul L, Golomb HMCancerA 10-year experience with combined modality therapy for stage III small cell lung carcinoma. Cancer. 1986 Nov 15; 58(10):2177-84.Cancer1986-11-15T00:00:001986A 10-year experience with combined modality therapy for stage III small cell lung carcinoma.77725Mintz U, Bitran JD, Cooksey JA, Desser RK, DeMeester TR, Golomb HMCancer treatment reportsHexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine. Cancer Treat Rep. 1978 Apr; 62(4):567-9.Cancer Treat Rep1978-04-01T00:00:001978Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine.6426295Richman CM, Makii MM, Weiser PA, Herbst ALAmerican journal of hematologyThe effect of lithium carbonate on chemotherapy-induced neutropenia and thrombocytopenia. Am J Hematol. 1984 May; 16(4):313-23.Am J Hematol1984-05-01T00:00:001984The effect of lithium carbonate on chemotherapy-induced neutropenia and thrombocytopenia.University of ChicagoArthurHerbstArthur L. Herbst41.78927490000000-87.601250000000001968Herbst, ArthurEmeritus/Emerita, ProfessorHarvey M.GolombHarvey M. Golomb41.78927490000000-87.601250000000002105Golomb, Harvey M.Professortrue1ProfessorProfessortrue1Emeritus/Emerita, ProfessorEmeritus/Emerita, Professor